Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.

@article{Papakostas2008PsychicAS,
  title={Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.},
  author={George I. Papakostas and Patrick McGrath and Jonathan W. Stewart and Dana Charles and Yin Chen and David Mischoulon and Christina M Dording and Maurizio Fava},
  journal={Psychiatry research},
  year={2008},
  volume={161 1},
  pages={116-20}
}
The purpose of this study was to examine whether the presence/severity of psychic and somatic anxiety symptoms predicted clinical response following a 12-week, flexible-dose (20-60 mg daily), open-label trial of fluoxetine for major depressive disorder (MDD). The presence and severity of psychic and somatic anxiety symptoms were assessed with the use of select subscales of the Symptom Questionnaire and the Hopkins Symptom Checklist among 518 outpatients with MDD. With the use of separate… CONTINUE READING